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Abstract Polylactosamines Neu5AcK2-3PLexL1-3PLexL1-
3PLex and Neu5AcK2-3PLNL1-3PLexL1-3PLex [Lex, GalL1-
4(FucK1-3)GlcNAc; LN, GalL1-4GlcNAc] decorate selectin
counterreceptors in human HL-60 cells. Here, we show that
HL-60 cell lysates catalyze distal K3-sialylation of LNL1-
3PLNL1-3PLN and LNL1-3PLexL1-3PLex efficiently, outlining
two potential sets of biosynthetic pathways leading to the selectin
ligands. In one set, K3-sialylation precedes internal fucosylation
of the polylactosamine backbone, whereas in the other one,
internal fucosylation is initiated before K3-sialylation. In
contrast to K3-sialylation, LNL1-3PLexL1-3PLex was K6-sialyl-
ated much less efficiently than LNL1-3PLNL1-3PLN by HL-60
cell lysates. Hence, internal fucosylation may regulate the extent
of K6-sialylation of polylactosamines in these cells.
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1. Introduction
Several sialylated and multifucosylated polylactosamines
are counterreceptors for the selectin family of cell adhesion
molecules in the vascular system. (i) The sequence Neu5AcK2-
3PLexL1-3PLex [Lex, GalL1-4(FucK1-3)GlcNAc] of N-glycans
in neutrophils and in the monocytic cell line U937 shows high
a⁄nity for E-selectin [1]. (ii) Multifucosylated gangliosides,
like Neu5AcK2-3PLNL1-3PLexL1-3PLexL1-3PLNL1-3PLL1-cer-
amide [LN, N-acetyllactosamine; L, lactose] of human pro-
myelocytic leukemia cells of line HL-60 also possess high af-
¢nity for E-selectin [2]. (iii) A related sequence, Neu5AcK2-
3PLexL1-3PLexL1-3PLex, is the major sialylated and multiply
fucosylated polylactosamine epitope decorating the P-selectin
counterreceptor PSGL-1 of HL-60 cells [3], and is assumed to
be important in the recognition between PSGL-1 and P-selec-
tin. (iv) A synthetic polylactosamine carrying two Neu5AcK2-
3PLexL1-3PLex epitopes is a highly potent inhibitor of L-selec-
tin-mediated adhesion of lymphocytes to lymph node endo-
thelium [4]. (v) Studies of ‘knock-out’ mice have shown that
besides Fuc-TVII [5], also the expression of Fuc-TIV is re-
quired for biosynthesis of fully functional leukocyte selectin
ligands in vivo [6].
Currently, the relative timing of sialylation and fucosylation
events in the biosynthesis of the sialylated and fucosylated
polylactosamines is only partially understood. The fucosyla-
tion of the distal LN unit probably occurs after the sialylation
[7], because no sialyltransferase capable of K3-sialylation of
the terminal Lex unit has been reported. By contrast, K3-sia-
lylated linear i-chains of polylactosamines can be K3-fucosy-
lated at distal sialylated LNs by Fuc-TVII and at internal
positions by Fuc-TIV [8^13]; these two enzymes are the major
fucosyltransferases of leukocytes [14,15]. However, Fuc-TIV
also transfers to all LN units of non-sialylated i-chains of
polylactosamines [10,12], raising the possibility of internal fu-
cosylation prior to the sialylation step, either during the elon-
gation of the backbone or right afterwards.
Here, we report that both the non-fucosylated polylactos-
amine LNL1-3PLNL1-3PLN and the internally pre-fucosylated
LNL1-3PLexL1-3PLex were e⁄ciently K3-sialylated by HL-60
cell lysates. This implies that internal backbone fucosylation,
intrinsically, may either precede or follow distal K3-sialylation
during the biosynthesis of selectin ligands in HL-60 cells. In
contrast to K3-sialylation, LNL1-3PLexL1-3PLex was K6-sialyl-
ated less e⁄ciently than LNL1-3PLNL1-3PLN. This, in turn,
suggests that the expression of K6-sialylated polylactosamines
may be regulated in part by internal fucosylation of the
chains.
2. Materials and methods
2.1. The cell lysates
Human HL-60 cells (American Type Culture Collection, Rockville,
MD, USA) were cultured in RPMI 1640 medium (Life Technologies
Ltd., Paisley, UK), supplemented with 10% fetal calf serum, 10 mM
HEPES, 2 mM L-glutamine and 100 Wg/ml gentamicin at 37‡C in 5%
CO2. They were subcultured twice a week at a ratio of 1:3. The cells
were lysed in the presence of a mixture of protease inhibitors (16 Wg/
ml benzamidine HCl, 10 Wg/ml phenanthroline, 10 Wg/ml aprotinin,
10 Wg/ml leupeptin, 10 Wg/ml pepstatin A, 1 mM PMSF; Pharmingen,
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San Diego, CA, USA) in 1% Triton X-100 on ice (lysate 1) or soni-
cated in ice cold water, and then lysed in 1% Triton X-100 on ice
(lysate 2). Protein concentrations were determined with the BCA Pro-
tein Assay Reagent Kit 23225 (Pierce, Rockford, IL, USA).
2.2. Oligosaccharides
The acceptor saccharides LNL1-3PLNL1-3PLN [16] and LNL1-
3PLexL1-3PLex were described previously [17]. The marker Neu5-
AcK2-3PLNL1-3PLNL1-3PLN was synthesized as described in [17]. Its
MALDI-TOF mass spectrum revealed a major signal at m/z 1403.6
that was assigned to the expected pseudomolecular ion [M-H]3 (calc.
monoisotopic m/z 1403.5). Neu5AcK2-3PLNL1-3PLexL1-3PLex marker
was also described in [17]. Its MALDI-TOF mass spectrum revealed a
major peak at m/z 1695.6 that was assigned to the [M-H]3 ion of the
expected nonasaccharide (calc. monoisotopic m/z 1695.6); another
signal at m/z 1531.5 was assigned to [M-H]3 of an analog that had
lost one fucose unit by L-elimination at the reducing end (calc. mono-
isotopic m/z 1531.5). Neu5AcK2-6PLNL1-3PLNL1-3PLN marker was
synthesized from LNL1-3PLNL1-3PLN using K6-sialyltransferase of
rat liver (Boehringer-Mannheim, Germany). The MALDI-TOF mass
spectrum showed a major signal at m/z 1403.3 (calc. monoisotopic m/z
for [M-H]3 of Neu5AcGal3GlcNAc3 1403.5). The 1H-NMR spectrum
revealed signals of the sialylated Gal H1, Neu5Ac H3-eq and Neu5Ac
H3-ax at 4.455, 2.670, and 1.722 ppm, respectively; they closely re-
sembled the signals of Neu5AcK2-6PLNL1-3PLNL-OR reported by
Kashem et al. [18]. The Neu5AcK2-6PLNL1-3PLexL1-3PLex marker
was synthesized from LNL1-3PLexL1-3PLex by the K6-sialyltransferase
of rat liver. Its 1H-NMR spectrum revealed signals of the sialylated
Gal H1, Neu5Ac H3-eq and Neu5Ac H3-ax at 4.455, 2.668 and 1.722
ppm, respectively. For Neu5AcK2-6PLNL1-3PLexL-OR, very similar
data have been reported [18]. The MALDI-TOF mass spectrum re-
vealed a major signal at m/z 1695.2 that was assigned to the [M-H]3
ion of the expected nonasaccharide (calc. average m/z 1696.6); anoth-
er signal at m/z 1531.5 was assigned to the [M-H]3 ion of the L-
elimination product that had lost one fucose unit at the reducing
end (calc. average m/z 1532.4).
2.3. Sialyltransferase reactions catalyzed by HL-60 cell lysates and
general plan of the product analysis
The unlabelled polylactosamine acceptors (2^20 nmol), the donor
CMP-[14C]Neu5Ac [5 nmol, 500 000 dpm; a mixture of CMP-Neu5-
Ac, disodium salt (Sigma, St. Louis, MO, USA) and CMP-
[14C]Neu5Ac, ammonium salt, Amersham International (Bucking-
hamshire, UK)] and the HL-60 cell lysate (5 Wl, 44^50 Wg protein)
were incubated in a total volume of 10 Wl in 50 mM Na-cacodylate pH
6.5 for 60 min at 37‡C. The incubation conditions resembled those
described for di¡erent acceptors by other researchers [19,20], and the
extent of [14C]Neu5Ac transfer was limited to less than 0.3% con-
sumption of the donor. The reactions were terminated by cooling
on ice and by adding ice cold ethanol (10 Wl). Finally, 100 Wl water
was added and the samples were frozen and stored at 325‡C until the
time of the analysis.
The product oligosaccharides were isolated by gel ¢ltration HPLC,
ensuing anion exchange HPLC, and were quantitated by liquid scin-
tillation counting. The formation of 14C-labelled K-monosialoproducts
was established by cleavage with sialidase from Arthrobacter ureafa-
ciens, and by MALDI-TOF mass spectrometry. For subsequent di¡er-
entiation between linkage isomers, the products were treated with
Newcastle disease virus (NDV) sialidase, which cleaves K3-bonded,
but not K6-linked Neu5Ac units; the liberated [14C]Neu5Ac and the
resistant [14C]oligosaccharide were isolated chromatographically from
the enzymatic digests. The NDV-sialidase-resistant fraction obtained
from [14C]sialylated LNL1-3PLNL1-3PLN was identi¢ed in a co-chro-
matography experiment with synthetic Neu5AcK2-6PLNL1-3PLNL1-
3PLN.
2.4. Chromatographic methods
Gel ¢ltration was performed in a column of Superdex Peptide HR
10/30 (Pharmacia, Uppsala, Sweden) at a £ow of 1 ml/min with
50 mM NH4HCO3. The runs of marker oligosaccharide samples rang-
ing between 10 pmol and 10 nmol were monitored by UV absorption
at 205 or 214 nm. N-Acetylglucosamine eluted at 17.1 min, N-acetyl-
neuraminic acid at 16.0 min. Neu5AcK2-3PLNL1-3PLNL1-3PLN and
Neu5AcK2-6PLNL1-3PLNL1-3PLN markers peaked at 12.6 þ 0.1 min
and the peaks of both sialoglycans were con¢ned between 11.9 þ 0.1
min and 13.3 þ 0.1 min, regardless of the sample size. The fucosylated
sialoglycan markers Neu5AcK2-3PLNL1-3PLexL1-3PLex and Neu5-
AcK2-6PLNL1-3PLexL1-3PLex peaked at 12.4 þ 0.1 min and the peaks
were con¢ned consistently between 11.7 þ 0.1 min and 13.1 þ 0.1 min.
Anion exchange chromatography on a Mono Q (5/5) column (Phar-
macia) was performed essentially as in [21]. Sharp, symmetrical peaks
of Neu5AcK2-3P and Neu5AcK2-6P derivatives of LNL1-3PLNL1-
3PLN, as well as Neu5AcK2-3P and Neu5AcK2-6P derivatives of
LNL1-3PLexL1-3PLex (10 pmol to 10 nmol) eluted between 8.6 and
9.7 min from the column; Neu5Ac marker eluted at 11.1 min. High-
pH anion exchange chromatography (HPAEC) was performed on a
(4U250 mm) Dionex CarboPac PA-1 column (Dionex, Sunnyvale,
CA, USA), using a linear gradient of 25^200 mM NaOAc in 100
mM NaOH over 150 min as previously described [17]. The marker
saccharides were detected by monitoring the whole run with a pulsed
amperometric detector (PAD); radioactive sialyltransferase products
were collected by recovering the appropriate peaks manually; these
were neutralized with 0.4 M acetic acid, and were quantitated by
scintillation counting.
2.5. Enzymatic degradations
Degradations with A. ureafaciens sialidase (EC 3.2.1.18, Boehr-
inger-Mannheim) were performed as previously described [22]. Hy-
drolyses with NDV sialidase (EC 3.2.1.18, Oxford Glycosysytems,
Abingdon, UK) were carried out by dissolving dry monosialylated
saccharides (2^5 pmol) in 19 Wl 50 mM sodium acetate pH 5.5 and
adding 1 mU of the enzyme in 1 Wl of 10 mM phosphate bu¡er pH
7.0. The reaction mixtures were incubated overnight at 37‡C [23^25].
The oligosaccharide products were separated from the liberated
[14C]Neu5Ac by Superdex chromatography. The NDV sialidase
cleaves only K3-bonded sialic acids from monosialoglygans [23,25],
but in oligo- and polysialic acid groups it also cleaves K8-linkages [24].
2.6. Analytical methods
Aliquots of the fractions containing radiolabelled oligosaccharides
and liberated [14C]Neu5Ac were scintillation counted; in experiment 1
the aqueous samples were mixed with two volumes of Optiphase Hi-
safe (Wallac, Turku, Finland) and in experiment 2, the samples were
deposited on small strips of ¢lter paper and counted as described in
[26]. For MALDI-TOF mass spectrometry with a BIFLEX instru-
ment (Bruker-Franzen Analytik, Bremen, Germany), neutral oligosac-
charides (5^15 pmol) were mixed in a 2,5-dihydroxybenzoic acid ma-
trix using the positive ion delayed extraction mode [17]. Sialylated
oligosaccharides were investigated in a 2,4,6-trihydroxyacetophen-
one/acetonitrile/aqueous ammonium citrate matrix as described in
[27], utilizing the linear negative ion mode with delayed extraction;
marker samples of 5^10 pmol were used in the experiments, but the
samples of the actual products amounted only to 0.8 pmol. NMR
spectroscopy was performed in D2O at 23‡C as described in [17].
3. Results
3.1. Sialyltransferase activities present in HL-60 cell lysates
Two polylactosamines, the fucose-free hexasaccharide
LNL1-3PLNL1-3PLN and the doubly fucosylated octasaccha-
ride LNL1-3PLexL1-3PLex, were incubated with CMP-
[14C]Neu5Ac and HL-60 cell lysates. The product oligosac-
charides were isolated by gel ¢ltration and anion exchange
chromatography and were quantitated by liquid scintillation
counting. The data of Table 1 show that signi¢cant transfer
rates of sialic acid were observed with both acceptors.
3.2. Characterization of the [14C]sialylated products by
MALDI-TOF mass spectrometry and sialidase treatments
The MALDI-TOF mass spectrum of the [14C]sialylation
product of LNL1-3PLNL1-3PLN revealed in the molecular
ion region a principal signal of m/z 1403.3 (Fig. 1A) that
was assigned to the molecular ion [M-H]3 of the monosialo-
glycan Neu5AcK2-3/6PLNL1-3PLNL1-3PLN (calc. monoiso-
topic m/z 1403.5). In the same way, the [14C]sialylation prod-
uct of LNL1-3PLexL1-3PLex revealed a major signal of m/z
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1695.7 (Fig. 1B) that was assigned to the molecular ion
[M-H]3 of Neu5AcK2-3/6PLNL1-3PLexL1-3PLex (calc. mono-
isotopic m/z 1695.6). A smaller peak at m/z 1531.7 was tenta-
tively assigned to a sialylated L-elimination product devoid of
the fucosyl unit at the reducing end (calc. monoisotopic m/z
1531.5). These features of Fig. 1B closely resemble those ob-
tained from the marker compounds Neu5AcK2-3PLNL1-
3PLexL1-3PLex and Neu5AcK2-6PLNL1-3PLexL1-3PLex. Both
product spectra of Fig. 1 also revealed small unidenti¢ed sig-
nals around m/z 1200 and 1565.
A treatment with the sialidase from A. ureafaciens released
more than 95% of [14C]Neu5Ac from both products (Table 1),
establishing the presence of K-linked sialic acid. The
[14C]monosialylated product oligosaccharides were treated
with NDV sialidase to liberate the K3-bonded [14C]sialic
acid. The data of Table 1 show that comparable amounts of
K3-sialylated products were formed from the fucose-free
LNL1-3PLNL1-3PLN and the internally pre-fucosylated
LNL1-3PLexL1-3PLex by the sialyltransferase activities of
HL-60 cell lysates. Hence, the presence of internal K3-bonded
fucosyl groups in the acceptor polylactosamine did not inhibit
K3-sialylation to any major extent. This was true at 0.20 mM
and 2.0 mM acceptor concentrations.
3.3. Chromatographic identi¢cation of
Neu5AcK2-6PLNL1-3PLNL1-3PLN in the NDV sialidase-
resistant fraction obtained from LNL1-3PLNL1-3PLN
The NDV sialidase-resistant fraction of sialyltransferase
products is often considered to consist of K6-sialylated sac-
charides. To con¢rm this notion, we mixed non-radiolabelled
marker saccharides Neu5AcK2-3PLNL1-3PLNL1-3PLN and
Neu5AcK2-6PLNL1-3PLNL1-3PLN with the K-[14C]sialylated,
NDV sialidase-resistant products of LNL1-3PLNL1-3PLN
(239 cpm) generated by HL-60 cells, and subjected the mixture
to HPAE chromatography. As shown in Fig. 2, most of the
radioactivity, 139 cpm, was recovered in peaks 1 and 3, rep-
resenting Neu5AcK2-6PLNL1-3PLNL1-3PLN and its reducing
end ManNAc epimer, Neu5AcK2-6PLNL1-3PLNL1-3GalL1-
4ManNAc, respectively. (The ManNAc epimer was probably
generated by base-catalyzed epimerization during the HPAE
chromatography [28].) By contrast, peaks 2 and 4, represent-
Fig. 1. The molecular ion regions of MALDI-TOF mass spectra of
0.8 pmol samples of [14C]sialopolylactosamines generated by HL-60
cell lysates. A: Puri¢ed monosialylated oligosaccharide products
from LNL1-3PLNL1-3PLN. B: Puri¢ed monosialylated oligosaccha-
ride products from LNL1-3PLexL1-3PLex.
Fig. 2. HPAEC chromatography of a mixture consisting of (i) the
NDV sialidase-resistant, 14C-labelled sialyltransferase products from
LNL1-3PLNL1-3PLN and (ii) the unlabelled markers Neu5AcK2-
3PLNL1-3PLNL1-3PLN and Neu5AcK2-6PLNL1-3PLNL1-3PLN. The
trace shows the detector response and the columns represent the ra-
dioactivity of individual fractions collected manually. Peak 1 con-
tains Neu5AcK2-6PLNL1-3PLNL1-3PLN and peak 3 its ManNAc epi-
mer, whereas peaks 2 and 4 correspond to the Neu5AcK2-3PLNL1-
3PLNL1-3PLN and the ManNAc epimer, respectively.
Table 1
Rates of sialyltransfer reactions catalyzed by HL-60 cell lysates (pmol/mg/h)
Lysate
number
Acceptor Total K-transfer K3-Transfer K6-Transfer
[14C]Neu5Ac transferred
to acceptorsa
K-linked [14C]Neu5Ac
in isolated productsb
K3-linked [14C]Neu5Ac
in isolated productsc
K6-linked [14C]Neu5Ac
in isolated productsd
1 LN-LN-LN, 2.0 mM 320 þ 4 317 þ 2 228 þ 3 91.2 þ 0.9
1 LN-Lex-Lex, 2.0 mM 255 þ 13 248 þ 0.4 214 þ 6 39.9 þ 4.1
2 LN-LN-LN, 2.0 mM 177 þ 8 172 þ 3 101 þ 2 73.9 þ 6.5
2 LN-Lex-Lex, 2.0 mM 115 þ 7 113 þ 1 87.9 þ 0.6 26.6 þ 6.8
2 LN-LN-LN, 0.20 mM 22.8 þ 0.4 22.4 þ 0.1 12.6 þ 0.1 10.0 þ 0.2
2 LN-Lex-Lex, 0.20 mM 15.6 þ 0.1 15.1 þ 0.03 10.8 þ 0.2 4.6 þ 0.1
aAll values represent data from two parallel experiments and their means.
b[14C]Neu5Ac released from isolated products by A. ureafaciens sialidase.
c[14C]Neu5Ac released from isolated products by NDV sialidase.
dK-linked [14C]Neu5Ac resistant to NDV sialidase.
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ing residual Neu5AcK2-3PLNL1-3PLNL1-3PLN and its puta-
tive reducing end ManNAc epimer, respectively, together
yielded only 15 cpm of radioactivity. The data imply that
almost 90% of the NDV sialidase-resistant K-[14C]sialoglycans
formed from LNL1-3PLNL1-3PLN by HL-60 cell lysates were
chromatographically identical with Neu5AcK2-6PLNL1-
3PLNL1-3PLN.
3.4. Relative rates of synthesis of K6-sialylated products from
LNL1-3PLNL1-3PLN and LNL1-3PLexL1-3PLex
The rates of Neu5AcK2-6PLNL1-3PLNL1-3PLN synthesis in
six independent experiments are shown in Table 1. The activ-
ities of the HL-60 cell K6-sialyltransferase(s) found in the
LNL1-3PLNL1-3PLN experiments were signi¢cant but dis-
tinctly lower than those of K3-sialyltransferases. This was
true at 0.2 mM and 2 mM acceptor concentrations. These
data are similar to those reported in HL-60 cell lysates by
[19] using asialo-K1-acid glycoprotein as the acceptor.
The synthesis rates of the putative fucosylated sialoglycan
Neu5AcK2-6PLNL1-3PLexL1-3PLex in the HL-60 cell lysate
experiments were consistently less than half of the rates of
Neu5AcK2-6PLNL1-3PLNL1-3PLN synthesis. Hence, the pres-
ence of internal K3-bonded fucosyl groups in the acceptor
polylactosamines inhibited K6-sialylation markedly. It is not
yet clear whether both midchain fucose units were inhibitory.
4. Discussion
4.1. The K3-sialyltransferases of HL-60 cells recognize mainly
the distal LN unit of the polylactosamines
In the present experiments, the HL-60 lysates K3-sialylated
both the fucosylated polylactosamine LNL1-3PLexL1-3PLex
and the fucose-free analog LNL1-3PLNL1-3PLN at similar
rates, revealing only a 1.1^1.2-fold preference for the latter
(Table 1). This suggests that the K3-sialyltransferase(s) of
HL-60 cells, representing mainly ST3Gal IV [29^32], recog-
nized mainly the distal LN units, the other parts of the two
acceptors being structurally quite di¡erent [33]. In contrast,
rat liver ST3Gal III may recognize a longer epitope than the
distal LN, because it shows 1.5^1.9-fold reaction rates for
LNL1-3PLNL1-OR over LNL1-3PLexL1-OR [18].
4.2. Two sets of synthetic pathways leading to multiply
fucosylated K3-sialopolylactosamines are possible in
HL-60 cells
The present data complete two distinct sets of in vitro bio-
synthetic pathways leading from polylactosamine backbones
to the selectin ligands Neu5AcK2-3PLNL1-3PLexL1-3PLex and
Neu5AcK2-3PLexL1-3PLexL1-3PLex in HL-60 cells. Successful
K3-sialylation of LN-L1-3PLNL1-3PLN, together with the pre-
viously reported data on fucosylation of Neu5AcK2-3PLN-L1-
3PLNL1-3PLN by the concerted action of Fuc-TVII and Fuc-
TIV [12], rounds o¡ the set of pathways A of Fig. 3. On the
other hand, Fuc-TIV reactions [12] lead from the ¢nished
polylactosamine backbone to the internally fucosylated
LNL1-3PLexL1-3PLex, and the present data on the successful
K3-sialylation of this intermediate represent the middle step of
pathway B of Fig. 3; this step is concluded by the Fuc-TVII
reaction described previously [12]. In theory, internal fucosyl-
ations catalyzed by Fuc-TIV can take place in HL-60 cells
already during the elongation of the polylactosamine back-
bone; analogous reactions have been described in the gener-
ation of LNL1-3PLex [18] and LNL1-3PLexL1-3PLex determi-
nants in vitro [17]. However, a Fuc-TIV reaction at the distal
LN of a growing polylactosamine backbone [12] would inhibit
further chain extension and K3-sialylation in vitro [34] and in
vivo [10].
4.3. HL-60 cell lysates catalyze K6-sialylation of long i-type
polylactosamine backbones but analogous gangliosides are
not expressed by these cells
The present experiments showed that HL-60 cell lysates
readily catalyzed the reaction LNL1-3PLNL1-3PLNCNeu5Ac-
K2-6PLNL1-3PLNL1-3PLN, initiating pathway C of Fig. 3. The
detection of K6-sialyltransferase activity is in line with the
work of others who used asialoglycoproteins as acceptors
[19,20], and also with the reported presence of Neu5AcK2-
6PLNL1-3PLL1-ceramide among the gangliosides of these cells
[35]. However, the distinct K6-sialyltransferase activity of HL-
60 cell lysates towards long chain polylactosamine acceptors is
interesting in view of the reported absence of long chain K6-
sialopolylactosamines among the gangliosides of these cells
[35]. In contrast to the K6-sialylated gangliosides, a whole
variety of K3-sialylated gangliosides of long polylactosamine
chains are present among the gangliosides of HL-60 cells [35],
suggesting that functional K3-sialyltransferase, but not func-
tional K6-sialyltransferase, may co-localize with polylactos-
amine extension enzymes or reside at quite distal locations
in the membranes of Golgi or trans-Golgi network.
4.4. Internally fucosylated polylactosamines show diminished
acceptor activity for K6-sialyltransferase(s) of HL-60 cells
In the present K6-sialyltransferase reactions catalyzed by
HL-60 cell lysates, LNL1-3PLexL1-3PLex showed less than
half of the acceptor activity of the fucose-free analog LNL1-
3PLNL1-3PLN. Hence, the enzyme(s) of HL-60 cells resembles
the K6-sialyltransferase from rat liver, known to react more
slowly with the internally fucosylated LNL1-3PLexL1-OR than
with the fucose-free LNL1-3PLNL1-OR [18]. Indeed, reduced
K6-sialylation of internally fucosylated polylactosamines
Fig. 3. Pathways of in vitro biosynthesis of K3-sialylated and K6-
sialylated polylactosamines in human HL-60 cell lysates. SiaT3 and
SiaT6 refer to the K3- and K6-sialyltransferase reactions described in
the present experiments, respectively. FucTIV and FucTVII refer to
transferase reactions of free oligosaccharides catalyzed by recombi-
nant Fuc-TIV and Fuc-TVII, respectively, as described by Niemela«
et al. [12]. It is not yet known whether the recombinant Fuc-TIV
enzyme will catalyze the conversion of Neu5AcK2-6PLNL1-3PLNL1-
3PLN to Neu5AcK2-6PLNL1-3PLexL1-3PLex, but it is known that the
sialylated, distal LN unit does not react [11].
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(pathway D in Fig. 3) may be common because all K6-sialyl-
transferases reacting with LN appear to belong to the ST6Gal
I family [29]. Fucosylation at the terminal LN unit is known
to prevent K6-sialylation completely [36].
In view of the impaired ability of ST6Gal I-de¢cient mice to
mount immune responses [37], it will be interesting to learn
whether the polylactosamine sequences Neu5AcK2-6PLNL1-
3PLNL1-3PLN and Neu5AcK2-6PLNL1-3PLexL1-3PLex synthe-
sized in the present experiments play any essential roles in the
generation of immunoprotection.
4.5. Conclusions
Taken together, our present data describe properties inher-
ent in HL-60 cell sialyltransferases, showing that K3-sialyla-
tion per se may precede or follow internal, Fuc-TIV-catalyzed
K3-fucosylation of polylactosamine backbones. However, our
data do not show whether internal K3-fucosylation actually
precedes, follows or intermingles with the K3-sialylation reac-
tions in the Golgi or trans-Golgi network of living HL-60
cells. The data also suggest that K3-fucosylation of polylactos-
amine backbones at the peridistal LN units, intrinsically, will
inhibit K6-sialylation.
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